Application of vibrational spectroscopy and nuclear magnetic resonance methods for drugs pharmacokinetics research

Vladimir V Rafalskiy; Andrey Yu Zyubin; Ekaterina M Moiseeva; Galina S Kupriyanova; Ivan G Mershiev; Nadezhda O Kryukova; Igor I Kon; Ilya G Samusev; Yana D Belousova; Svetlana A Doktorova

doi:10.1515/dmpt-2022-0109

Application of vibrational spectroscopy and nuclear magnetic resonance methods for drugs pharmacokinetics research

Drug Metab Pers Ther. 2022 Sep 28;38(1):3-13. doi: 10.1515/dmpt-2022-0109. eCollection 2023 Mar 1.

Authors

Affiliations

¹ Department of Therapy of the Medical Institute of the IKBFU, Kaliningrad, Russia.
² REC "Fundamental and Applied Photonics, Nanophotonics", IKBFU, Kaliningrad, Russia.
³ Medical Institute of the IKBFU, Kaliningrad, Russia.
⁴ IPMS&IT IKBFU, Kaliningrad, Russia.
⁵ Department of Fundamental Medicine of the Medical Institute of the IKBFU, Kaliningrad, Russia.
⁶ REC "Fundamental and Applied Photonics, Nanophotonics", Kaliningrad, Russia.
⁷ Immanuel Kant Baltic Federal University Institute of Medicine - Clinical Trial Center of IKBFUA, Kaliningrad, Russia.

PMID: 36169571
DOI: 10.1515/dmpt-2022-0109

Abstract

Objectives: The development of new methods for determining the concentration of drugs is an actual topic today. The article contains a detailed review on vibrational spectroscopy and nuclear magnetic resonance methods using for pharmacokinetic research. This study is devoted to the possibility of using vibrational spectroscopy and 1H nuclear magnetic resonance spectroscopy to determine the concentration of drugs and the use of these groups of techniques for therapeutic drug monitoring.

Content: The study was conducted by using scientific libraries (Scopus, Web of Science Core Collection, Medline, GoogleScholar, eLIBRARY, PubMed) and reference literature. A search was conducted for the period from 2011 to 2021 in Russian and English, by combinations of words: 1H nuclear magnetic resonance (¹H NMR), vibrational spectroscopy, Surface-Enhanced Raman spectroscopy, drug concentration, therapeutic drug monitoring. These methods have a number of advantages and are devoid of some of the disadvantages of classical therapeutic drug monitoring (TDM) methods - high performance liquid chromatography and mass spectrometry. This review considers the possibility of using the methods of surface-enhanced Raman scattering (SERS) and ¹H NMR-spectroscopy to assess the concentration of drugs in various biological media (blood, urine), as well as to study intracellular metabolism and the metabolism of ophthalmic drugs. ¹Н NMR-spectroscopy can be chosen as a TDM method, since it allows analyzing the structure and identifying metabolites of various drugs. ¹Н NMR-based metabolomics can provide information on the side effects of drugs, predict response to treatment, and provide key information on the mechanisms of action of known and new drug compounds.

Summary and outlook: SERS and ¹Н NMR-spectroscopy have great potential for further study and the possibility of introducing them into clinical practice, including for evaluating the efficacy and safety of drugs.

Keywords: Raman spectroscopy; pharmacokinetics; pharmacometabolomics; quantitative NMR analysis; therapeutic drug monitoring.

Publication types

Review
Research Support, Non-U.S. Gov't

MeSH terms

Chromatography, High Pressure Liquid / methods
Drug-Related Side Effects and Adverse Reactions*
Humans
Magnetic Resonance Spectroscopy / methods
Mass Spectrometry
Metabolomics* / methods